CD274 and neoplasm: We established a syngenic, orthotopic colorectal mouse cancer model with MMR-proficient CT26-FL3 cells, and proved that administration of a relative low dose of OxP to the CT26-FL3 tumor-bearing mice resulted in a series of immunogenic effects inside the tumor, and significantly boosted effect of PD-L1 blockade in tumor burden control.